Please login to the form below

Breast Cancer Now

This page shows the latest Breast Cancer Now news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Tecentriq set for breast cancer filing, Ocrevus gets NICE thumbs down, NHS needs more cash

Daily Brief: Tecentriq set for breast cancer filing, Ocrevus gets NICE thumbs down, NHS needs more cash. ... Checkpoint inhibitor immunotherapy drugs have targeted other tumour types before turning to breast cancer, but now Roche's Tecentriq looks set to

Latest news

Daily Brief: Amgen offers Repatha deals in Europe, will Persephone slash Herceptin use?

Baroness Delyth Morgan, Chief Executive at UK charity Breast Cancer Now (pictured) said: “This marks a really promising step towards being able to safely offer patients a much shorter course of ... Herceptin remains one of the most important advances
NICE backs two advanced breast cancer drugs after price cuts

Women in England and Wales with advanced breast cancer can now get access to two CDK 4/6 inhibitor drugs - Pfizer’s Ibrance and Novartis’Kisqali - after pricing negotiations between the ... important breakthroughs for women with advanced breast
Dismay as NICE turns down first-line use of AZ's Faslodex

AstraZeneca's hopes of expanding the use of its breast cancer therapy Faslodex in the UK look rocky after NICE rejected the drug in draft guidance. ... Baroness Delyth Morgan, chief executive at medical charity Breast Cancer Now, said the verdict was
Novartis claims EU approval for breast cancer drug Kisqali

Novartis claims EU approval for breast cancer drug Kisqali. Firm's CDK4/6 inhibitor can now challenge Pfizer's Ibrance in Europe. ... Novartis can now challenge Pfizer's blockbuster breast cancer drug Ibrance in Europe after gaining approval for its
Clovis rockets on maintenance data in ovarian cancer

their indications into other indications such as breast cancer. ... Another candidate - AbbVie's veliparib - failed two phase III trials in April (in breast and lung cancer) and now looks unlikely to challenge the leaders.

More from news
Approximately 2 fully matching, plus 32 partially matching documents found.

Latest Intelligence

30 women leaders in UK healthcare (part 3)

28. Baroness Delyth Morgan, Breast Cancer Now Chief Executive. Delyth has been a central figure in breast cancer charities for more than 20 years, building the sector’s voice in health ... In 2015 she oversaw the merger of her organisation Breast
Engaging the digital healthcare professional

Two days after the student midwife’s tweet, UK organisation Breast Cancer Now shared its own response to the guidance, also tweeting to Pfizer and NICE and urging them to work ... Breast Cancer Now is followed by almost 40, 000, and its tweet, which it

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Client Services Director - Med Comms: Great salary and bebefits

Account Manager: £40, 000 - £45, 000 benefits

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Home based, Chief Medical Writer, Medical Communications: Excellent package

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Senior Account Manager: Competitive salary commensurate with experience

Healthcare PR Director: £100, 000 – £120, 000 benefits

Delivery Manager/ Head of Delivery – Executive Search: Neg

Home based, Senior Medical Writer, Medical Communications: Excellent package

Home based, Editorial Team Leader, Medical Communications: Excellent package

Client Services Director – Healthcare Advertising - London: Neg

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Editorial Director – Medical Education (MedComms): Neg

Business Unit Head, Medical Communications, London: Excellent package

Senior Project Manager - Medical Writing: Great salary and bebefits

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Home based, Principal Medical Writer, Medical Communications: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

FCB Halesway

A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...

Latest intelligence

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....